<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="2807">
  <stage>Registered</stage>
  <submitdate>8/06/2010</submitdate>
  <approvaldate>8/06/2010</approvaldate>
  <nctid>NCT01140581</nctid>
  <trial_identification>
    <studytitle>Optimal Timing of Dronedarone Initiation After Conversion in Patients With Persistent Atrial Fibrillation</studytitle>
    <scientifictitle>A Randomized, International, Multi-center, Open-label Study to Document Optimal Timing of Initiation of Dronedarone Treatment After Conversion With Loading Dose of Amiodarone in Patients With Persistent Atrial Fibrillation Requiring Conversion of AF.</scientifictitle>
    <utrn />
    <trialacronym>ARTEMIS Load</trialacronym>
    <secondaryid>2009-016818-24</secondaryid>
    <secondaryid>DRONE_C_03668</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Atrial Fibrillation</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Other cardiovascular diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: drugs - DRONEDARONE

Experimental: Group A - Amiodarone 600 mg daily for 1 week then 400 mg daily for 1 week then 200 mg daily for 2 weeks followed by dronedarone 400 mg twice daily for 8 weeks

Experimental: Group B - Amiodarone 600 mg daily for 1 week then 400 mg daily for 1 week then 200 mg daily for 2 weeks. Two weeks wash-out followed by dronedarone 400 mg twice daily for 6 weeks

Experimental: Group C - Amiodarone 600 mg daily for 1 week then 400 mg daily for 1 week then 200 mg daily for 2 weeks. Four weeks wash-out followed by dronedarone 400 mg twice daily for 4 weeks


Treatment: drugs: DRONEDARONE
Pharmaceutical form: tablet Route of administration: oral Dose regimen: 400 mg

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>AF recurrences - two consecutives 12-lead ECG or Trans-Telephonic ECG monitoring (TTEM) approximatively 10 minutes apart and both showing AF</outcome>
      <timepoint>one month after randomization</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>AF recurrences</outcome>
      <timepoint>two months after randomization</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Symptomatic bradycardia - Heart rate at rest &lt; 50 beats per minute</outcome>
      <timepoint>two months after randomization</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Tachycardia - Heart rate at rest &gt; 120 beats per minute</outcome>
      <timepoint>two months after randomization</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Dronedarone and amiodarone concentrations in plasma - Limited to a subset of countries</outcome>
      <timepoint>3 hours, 1 week, 2 weeks and 4 weeks after 1st Dronedarone intake</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Inclusion criteria:

        Screening:

          -  Persistent AF for more than 72 hours (documented by an ECG taken within the last 72
             hours) for whom cardioversion, anti-arrhythmic treatment and anticoagulation treatment
             are indicated in the opinion of the Investigator

          -  Naive of amiodarone treatment in the last three months

          -  QTc Bazett &lt; 500 ms on 12-lead ECG,

          -  At least one cardiovascular risk factor (i.e. age &gt; 70, hypertension, diabetes, prior
             cerebrovascular disease or left atrial diameter &gt;= 50 mm

        Randomization:

          -  Outpatient and Inpatients (except patients hospitalized during screening period for
             SAE)

          -  Sinus rhythm

          -  Effective oral anticoagulation verified by International Normalized Ratio/INR (target
             &gt; 2)

          -  QTc Bazett &lt; 500 ms and PR &lt; 280 ms on 12-lead ECG

          -  Completed treatment period with amiodarone (28 days Â± 2 days)</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Exclusion criteria:

        Screening:

          -  Contraindication to oral anticoagulation

          -  Acute condition known to cause AF

          -  Permanent AF

          -  Paroxysmal AF

          -  Bradycardia &lt; 50 bpm on the 12-lead ECG

          -  Clinically overt congestive heart failure:

               -  with New York Heart Association (NYHA) classes III and IV heart failure

               -  with LVEF &lt; 35%

               -  or NYHA class II with a recent decompensation requiring hospitalization or
                  referral to a specialized heart failure clinic

               -  or unstable hemodynamic conditions

          -  Severe hepatic impairment

          -  Previous treatment with class I or class III anti-arrhythmic drugs (including sotalol)
             if taken less than one week

          -  Previous history of amiodarone intolerance or toxicity

          -  Any contraindication as per dronedarone and amiodarone labelling

          -  Wolff-Parkinson-White Syndrome

          -  Previous ablation for atrial fibrillation or any planned ablation in the next 2 months

          -  Contraindicated concomitant treatment:

               -  Potent cytochrome P450 (CYP3A4) inhibitors

               -  Use of drugs or herbal products that prolong the QT interval and known to
                  increase the risk of Torsades de Pointes

               -  Class I or III anti-arrhythmic drugs (including sotalol)

        Randomization:

          -  Bradycardia &lt; 50 bpm on the 12-lead ECG

          -  Clinically overt congestive heart failure:

               -  with New York Heart Association (NYHA) classes III and IV heart failure

               -  with LVEF &lt; 35%

               -  or NYHA class II with a recent decompensation requiring hospitalization or
                  referral to a specialized heart failure clinic

               -  or unstable hemodynamic conditions

          -  Severe hepatic impairment

          -  Previous treatment with class I or class III anti-arrhythmic drugs (including sotalol)
             if taken less than one week

          -  Patient in whom the following contraindicated concomitant treatment is mandatory:

               -  Potent cytochrome P450 (CYP3A4) inhibitors

               -  Use of drugs or herbal products that prolong the QT interval and known to
                  increase the risk of Torsades de Pointes

               -  Class I or III anti-arrhythmic drugs (including sotalol)

        The above information is not intended to contain all considerations relevant to a patient's
        potential participation in a clinical trial.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate />
    <actualstartdate>1/09/2010</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>402</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/12/2011</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <hospital>Investigational Site Number 009 - Adelaide</hospital>
    <hospital>Investigational Site Number 013 - Ballarat</hospital>
    <hospital>Investigational Site Number 002 - Garran</hospital>
    <hospital>Investigational Site Number 007 - Herston</hospital>
    <hospital>Investigational Site Number 012 - Hobart</hospital>
    <hospital>Investigational Site Number 006 - Liverpool</hospital>
    <hospital>Investigational Site Number 010 - Maroubra</hospital>
    <hospital>Investigational Site Number 001 - Nedlands</hospital>
    <hospital>Investigational Site Number 004 - New Lambton</hospital>
    <hospital>Investigational Site Number 008 - Redcliffe</hospital>
    <hospital>Investigational Site Number 011 - South Brisbane</hospital>
    <hospital>Investigational Site Number 005 - Southport</hospital>
    <hospital>Investigational Site Number 003 - Woolloongabba</hospital>
    <postcode>5000 - Adelaide</postcode>
    <postcode>3350 - Ballarat</postcode>
    <postcode>2605 - Garran</postcode>
    <postcode>4006 - Herston</postcode>
    <postcode>7000 - Hobart</postcode>
    <postcode>2170 - Liverpool</postcode>
    <postcode>2035 - Maroubra</postcode>
    <postcode>6009 - Nedlands</postcode>
    <postcode>2305 - New Lambton</postcode>
    <postcode>4020 - Redcliffe</postcode>
    <postcode>4101 - South Brisbane</postcode>
    <postcode>4215 - Southport</postcode>
    <postcode>4102 - Woolloongabba</postcode>
    <countryoutsideaustralia>
      <country>Austria</country>
      <state>Braunau</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Austria</country>
      <state>Innsbruck</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Austria</country>
      <state>Linz</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Austria</country>
      <state>MÃ¶dling</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Austria</country>
      <state>Vienna</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Austria</country>
      <state>Wien</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Estonia</country>
      <state>Tallinn</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Finland</country>
      <state>HyvinkÃ¤Ã¤</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Finland</country>
      <state>Pori</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Finland</country>
      <state>SeinÃ¤joki</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Avignon Cedex 9</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>BEZIERS Cedex</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Bron</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Cholet</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Lyon Cedex 03</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>NIMES Cedex 9</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>POITIERS Cedex</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Toulouse Cedex 3</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Valence Cedex 9</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Vandoeuvre Les Nancy</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Berlin</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Bernau</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Bonn</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Dresden</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Frankfurt am Main</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Hamburg</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Heidenau</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Kiel</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Ludwigsburg</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Paderborn</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Israel</country>
      <state>Ashkelon</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Israel</country>
      <state>Beer Yaakov</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Ancona</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Barga</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Catania</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Como</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Cortona</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Mestre</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Palermo</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Roma</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>San Daniele Del Friuli</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Varese</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Korea, Republic of</country>
      <state>Seoul</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Korea, Republic of</country>
      <state>Suwon</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Mexico</country>
      <state>Aguascalientes</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Mexico</country>
      <state>Chihuahua</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Mexico</country>
      <state>Guadalajara</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Mexico</country>
      <state>Leon</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Mexico</country>
      <state>Mexico</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Mexico</country>
      <state>Monterrey</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Mexico</country>
      <state>Queretaro</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Mexico</country>
      <state>Saltillo</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Mexico</country>
      <state>Tijuana</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Netherlands</country>
      <state>Amsterdam</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Netherlands</country>
      <state>Goes</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Netherlands</country>
      <state>Groningen</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Netherlands</country>
      <state>Maastricht</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Netherlands</country>
      <state>Rotterdam</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Portugal</country>
      <state>Amadora</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Portugal</country>
      <state>Lisboa</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Spain</country>
      <state>El Palmar (MURCIA)</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Spain</country>
      <state>Hospitalet de Llobregat</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Spain</country>
      <state>La CoruÃ±a</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Spain</country>
      <state>LLeida</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Spain</country>
      <state>Madrid</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Spain</country>
      <state>Majadahonda</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Spain</country>
      <state>Sevilla</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Spain</country>
      <state>Tarragona</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Spain</country>
      <state>Valencia</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Switzerland</country>
      <state>Basel</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Switzerland</country>
      <state>St.Gallen</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Taiwan</country>
      <state>Kaohsiung Hsien,</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Taiwan</country>
      <state>Kaohsiung</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Taiwan</country>
      <state>Taichung City</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Taiwan</country>
      <state>Taichung</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Taiwan</country>
      <state>Taipei</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Taiwan</country>
      <state>Tao Yuan Hsien</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Belfast</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Bournemouth</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Carshalton</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Gloucester</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Wrexham</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Sanofi</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>Primary Objective:

      - Evaluate the rate of Atrial Fibrillation (AF) recurrences one month after randomization
      according to different timings of initiation of dronedarone.

      Secondary Objective:

        -  Evaluate the rate of AF recurrences two months after randomization.

        -  Assess the safety of the change from amiodarone to dronedarone

        -  Assess dronedarone safety

        -  Explore dronedarone and its active metabolite plasma level (in a subset of countries)

        -  Explore potential Pharmacokinetic (PK) interaction between dronedarone and amiodarone
           (in a subset of countries)</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT01140581</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Clinical Sciences &amp; Operations</name>
      <address>Sanofi</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>